CME Group turned in a record-breaking first quarter in 2026, beating Wall Street on both earnings and revenue. The stock still slipped 1.5% in pre-market trading.
Adjusted EPS came in at $3.36, topping the analyst consensus of $3.31. Revenue reached $1.9 billion, up 14% from the same period last year and ahead of the $1.85 billion estimate.
The standout number was average daily volume. CME recorded 36.2 million contracts per day — up 22% year-over-year — with records set across all six asset classes it operates.
CME Group Inc., CME
Net income for the quarter was $1.2 billion, a 20% jump from Q1 2025. Adjusted operating income climbed to $1.4 billion.
Clearing and transaction fees — CME’s core revenue line — hit a record $1.5 billion for the quarter. Market data revenue also set a new high at $224 million.
The total average rate per contract was $0.652. Non-U.S. average daily volume reached a record 11.4 million contracts, up 30% compared with Q1 2025.
CME’s business model benefits when markets move sharply. When uncertainty rises, traders and institutions rush to hedge positions using futures and derivatives — CME’s core products.
During Q1, elevated uncertainty around global interest rates and geopolitical tensions pushed more market participants to CME’s platform. That translated directly into higher trading volumes and fees.
The exchange saw strong demand across interest rate and equity index products in particular. These categories tend to see the most activity when rate expectations are shifting.
CME paid out approximately $2.7 billion in dividends during the quarter. The company also repurchased $536 million in common stock.
As of March 31, 2026, CME held $2.6 billion in cash and carried $3.4 billion in debt.
Despite the pre-market dip, the underlying numbers pointed to strong operational momentum. Non-U.S. volumes growing 30% year-over-year suggests international demand for CME’s products is accelerating.
The record market data revenue of $224 million is also worth flagging. That segment tends to be high-margin and recurring, adding some stability to the fee-based volume business.
Q1 2026 marks CME’s strongest quarter on record by several key measures, with records across revenue, volume, clearing fees, and market data.
The post CME Group (CME) Stock Dips Despite Best Quarter in Company History appeared first on CoinCentral.


